The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first and only monotherapy for adults with major depressive ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The U.S. Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray as a standalone therapy for adults with treatment-resistant depression. The spray, Spravato ...

calls for the FDA to entirely withdraw the drug’s approval. President Donald Trump, however, has been inconsistent, saying that he doesn’t plan to block access to the abortion pills while ...

The Nigerian Communications Commission has approved requests from network operators for tariff adjustments in response to rising operational costs, marking the first change in rates since 2013.

The Federal Government, through the Nigerian Midstream and Downstream Petroleum Regulatory Authority, has announced the approval of a licence for the construction of a new refinery. The approval ...

The Houston Police Department said drug-addicted rats have been digging through old evidence stashes, and they've developed an appetite for the devil's lettuce. "We got 400,000 pounds of marijuana ...

Be sure to come back regularly for the latest updates. Currently, the drug's FDA-approved loading regimen features three doses given 14 days apart, plus a fourth dose 30 days after the third.

Washington — The House approved the Laken Riley Act on Wednesday, signing off on the Senate's changes to the legislation aimed at expanding the federal government's mandate to detain immigrants ...